Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biologic discontinuation studies: a systematic review of methods.
Yoshida K, Sung YK, Kavanaugh A, Bae SC, Weinblatt ME, Kishimoto M, Matsui K, Tohma S, Solomon DH. Yoshida K, et al. Among authors: kavanaugh a. Ann Rheum Dis. 2014 Mar;73(3):595-9. doi: 10.1136/annrheumdis-2013-203302. Epub 2013 May 30. Ann Rheum Dis. 2014. PMID: 23723316 Free PMC article. Review.
Rheumatic disease in the elderly: rheumatoid arthritis.
Tutuncu Z, Kavanaugh A. Tutuncu Z, et al. Among authors: kavanaugh a. Rheum Dis Clin North Am. 2007 Feb;33(1):57-70. doi: 10.1016/j.rdc.2006.12.006. Rheum Dis Clin North Am. 2007. PMID: 17367692 Review.
Biologic agents in rheumatology: safety considerations.
Lee SJ, Kavanaugh A. Lee SJ, et al. Among authors: kavanaugh a. Rheum Dis Clin North Am. 2006 Dec;32 Suppl 1:3-10. doi: 10.1016/s0889-857x(07)70003-0. Rheum Dis Clin North Am. 2006. PMID: 17410696 Review. No abstract available.
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial.
Weinblatt ME, Kavanaugh A, Burgos-Vargas R, Dikranian AH, Medrano-Ramirez G, Morales-Torres JL, Murphy FT, Musser TK, Straniero N, Vicente-Gonzales AV, Grossbard E. Weinblatt ME, et al. Among authors: kavanaugh a. Arthritis Rheum. 2008 Nov;58(11):3309-18. doi: 10.1002/art.23992. Arthritis Rheum. 2008. PMID: 18975322 Free article. Clinical Trial.
An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.
Weinblatt ME, Kavanaugh A, Genovese MC, Musser TK, Grossbard EB, Magilavy DB. Weinblatt ME, et al. Among authors: kavanaugh a. N Engl J Med. 2010 Sep 30;363(14):1303-12. doi: 10.1056/NEJMoa1000500. Epub 2010 Sep 22. N Engl J Med. 2010. PMID: 20879879 Free article. Clinical Trial.
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.
Genovese MC, Kavanaugh A, Weinblatt ME, Peterfy C, DiCarlo J, White ML, O'Brien M, Grossbard EB, Magilavy DB. Genovese MC, et al. Among authors: kavanaugh a. Arthritis Rheum. 2011 Feb;63(2):337-45. doi: 10.1002/art.30114. Arthritis Rheum. 2011. PMID: 21279990 Free article. Clinical Trial.
577 results